Kringle Pharma Inc - Company Review
Kringle Pharma Inc - Company ReviewSummary
Kringle Pharma Inc (Kringle Pharma) is a biopharmaceutical company that conducts research and development of treatments. The company’s activities include research and development of pharmaceuticals and regenerative medicine for cancer and incurable diseases. Its products include hepatocyte growth factor and its intramolecular fragment. Kringle Pharma’s hepatocyte growth factor is used in the treatment of amyotrophic lateral sclerosis, acute spinal cord injury and acute kidney injury. The company also provides regeneration of various tissues and organs including the liver, the kidneys, skin, blood vessels and the nervous system. Its intramolecular fragment is used in the treatment of solid tumors. The company is developing recombinant human HGF for the treatment of acute renal failure, and CNS diseases. Kringle Pharma is headquartered in Ibaraki, Japan.
This comprehensive company report of Kringle Pharma Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.